verapamil has been researched along with peptide phi in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bjøro, T; Gautvik, KM; Gordeladze, J; Haug, E; Iversen, JG; Ostberg, BC; Sand, O; Torjesen, PA | 1 |
Egan, JJ; Gardner, JD; Jensen, RT; Slimak, GG; Stark, HA | 1 |
2 other study(ies) available for verapamil and peptide phi
Article | Year |
---|---|
Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenylyl Cyclases; Animals; Calcium; Cell Membrane; Cells, Cultured; Colforsin; Cyclic AMP; Membrane Potentials; Peptide PHI; Pituitary Gland; Prolactin; Rats; Secretory Rate; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide; Verapamil | 1987 |
Effect of verapamil on the cyclic AMP-mediated pathway for amylase secretion in rat pancreatic acini.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amylases; Animals; Colforsin; Cyclic AMP; Intercellular Signaling Peptides and Proteins; Male; Pancreas; Peptide PHI; Peptides; Rats; Rats, Sprague-Dawley; Secretin; Vasoactive Intestinal Peptide; Verapamil | 1993 |